PULMONARY CAPILLARY HAEMANGIOMATOSIS

PULMONARY CAPILLARY HAEMANGIOMATOSIS was reported 55 times

PULMONARY CAPILLARY HAEMANGIOMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Methylating Agent [EPC] 1 0.0010
1 Prostacyclin Receptor Agonist [EPC] 6 0.0002
2 Phosphodiesterase 5 Inhibitor [EPC] 24 0.0002
3 Prostacycline Vasodilator [EPC] 22 0.0002
4 Endothelin Receptor Antagonist [EPC] 21 0.0001
5 Cardiac Glycoside [EPC] 6 0.0001
6 RNA Synthetase Inhibitor Antibacterial [EPC] 1 0.0001
7 Tetracycline-class Drug [EPC] 4 0.0001
8 Aldosterone Antagonist [EPC] 8 0.0001
9 Antimetabolite Immunosuppressant [EPC] 1 0.0000
10 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
11 Provitamin D2 Compound [EPC] 1 0.0000
12 Polyene Antifungal [EPC] 1 0.0000
13 alpha-Adrenergic Blocker [EPC] 3 0.0000
14 Alkylating Drug [EPC] 4 0.0000
15 Antidote [EPC] 1 0.0000
16 HER2/neu Receptor Antagonist [EPC] 1 0.0000
17 Janus Kinase Inhibitor [EPC] 2 0.0000
18 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
19 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
20 Factor Xa Inhibitor [EPC] 3 0.0000
21 Aminosalicylate [EPC] 1 0.0000
22 beta-Adrenergic Blocker [EPC] 3 0.0000
23 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
24 Osmotic Laxative [EPC] 2 0.0000
25 Azole Antifungal [EPC] 1 0.0000
26 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
27 Estrogen [EPC] 1 0.0000
28 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
29 Loop Diuretic [EPC] 2 0.0000
30 Corticosteroid [EPC] 5 0.0000
31 Opioid Agonist [EPC] 1 0.0000
32 Platinum-based Drug [EPC] 1 0.0000
33 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
34 Proton Pump Inhibitor [EPC] 2 0.0000
35 Kinase Inhibitor [EPC] 1 0.0000